By mid-March this year, announcements regarding the postponement or cancellation of meetings due to the COVID-19 pandemic had been made and an almost global lockdown was underway.
In this unprecedented context, the European Pharmacopoeia (Ph. Eur.) Commission and its 60 groups of experts and working parties, with the support of the national pharmacopoeia authorities and the EDQM, demonstrated their commitment to public health protection by adapting their traditional method of working to the new situation and constraints. Thanks to their efforts, the work of the Ph. Eur. continues to be assured.
The 166th Ph. Eur. Commission session, which would have brought together delegations from Europe and beyond for a face-to-face meeting in Strasbourg, France, was replaced by an electronic adoption of its agenda and work programme.
At this session, the Ph. Eur. Commission adopted 91 texts for publication in Ph. Eur. Supplement 10.4, including 11 new texts.
A new edition of the Technical Guide for the elaboration and use of monographs for immunological veterinary medicinal products (2020) was also approved by the Commission – more information can be found on the EDQM website here.
The list of all adopted texts will be made available on the EDQM website: Ph. Eur. Work Programme and Ph. Eur. publication schedule. These texts will be effective as of 1 April 2021 and will be published in Supplement 10.4 of the Ph. Eur.
The next session of the Ph. Eur. Commission will take place on 23 June 2020.
More information in the press release